申请人:Alcon Universal Ltd.
公开号:US20020037929A1
公开(公告)日:2002-03-28
The use of 3-benzolphenylacetic acids and derivatives, including nepafenac, to treat angiogenesis-related disorders, including ophthalmic angiogenesis-related disorders such as diabetic retinopathy and exudative macular degeneration, is disclosed.
公开了 3-苯酚苯乙酸及其衍生物(包括奈帕芬胺)用于治疗血管生成相关疾病,包括眼科血管生成相关疾病,如糖尿病视网膜病变和渗出性黄斑变性。